Cerecor Inc. to Present at Biotech Showcase 2016 in San Francisco
BALTIMORE-- Cerecor Inc. (NASDAQ:CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced that it will present at Biotech Showcase 2016 on Tuesday, January 12, 2016. The presentation is scheduled at 11:30 a.m., PST, in the Parc 55 Hilton Hotel, San Francisco.
About Cerecor
Cerecor Inc. is a Baltimore-based biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric diseases by addressing the unmet medical needs of underserved patient segments. We are committed to the development of drugs that improve lives by applying our extensive knowledge and experience in central nervous system disorders. For more information about the Company and its products, please visit: www.cerecor.com or contact Mariam E. Morris, Chief Financial Officer, at (443) 304-8002.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160104005372/en/
MacDougall Biomedical Communications
Doug MacDougall, 781-235-3060
or
Joe
Rayne, 781-235-3060
jrayne@macbiocom.com
Source: Cerecor Inc.
Released January 4, 2016